multiple myeloma disease specific programme (dsp) patient-level database (Adelphi Technology Inc)
Structured Review
Multiple Myeloma Disease Specific Programme (Dsp) Patient Level Database, supplied by Adelphi Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/database+programmer/multiple+sclerosis+disease+specific+programme/pm34110106-34-8-7
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: The presence and burden of cognitive issues: discordance between the perception of neurologists and people living with multiple sclerosis. Article Snippet: Therefore, the present study analysed the similarities and differences in reported perspectives of plwMS when dealing with MS (both RRMS and secondary progressive MS [SPMS]), their caregivers and their neurologists using the Article Title: Factors associated with increased severity of generalized myasthenia gravis among patients in the United States and Europe. Article Snippet: The analysis described here used data from the Article Title: Healthcare resource utilization and economic burden of multiple sclerosis in Chinese patients: results from a real-world survey. Article Snippet: This was a cross-sectional survey of physicians (including neurologists and rehabilitation specialists) and their consulting patients, from an analysis of secondary data drawn from the Article Title: Assessing the impact of relapses on patient outcomes in NMOSD Article Snippet: A. Kießlich , M. Kleman , S. Tursunova , J. Tibung , K. Myren , M. Unsworth , G. Castellano , E. Trenholm, N. Grant , L. Le Brocq , K. Fitzmaurice e Alexion Pharma GmbH, München, Deutschland Alexion, AstraZeneca Rare Disease, Horgen, Switzerland Alexion, AstraZeneca Rare Disease, Zürich, Switzerland Alexion, AstraZeneca Rare Disease Stockholm, Stockholm Sweden Adelphi Real World Bollington, Cheshire, United Kingdom Bioprocessing:Article Title: Shared Decision-Making in the Treatment of Multiple Sclerosis: Results of a Cross-Sectional, Real-World Survey in Europe and the United States Article Snippet: .. Data were drawn from the Adelphi |
